Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 23Neoplasm Metastasis 7Brain Neoplasms 5Prostatic Neoplasms 4Oligodendroglioma 2Neoplasms 2Glioma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Venous Thromboembolism 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Unilateral Breast Neoplasms 1Spinal Cord Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Meningioma 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Liposarcoma 1Glioblastoma 1Gastro-enteropancreatic neuroendocrine tumor 1Ependymoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiovascular Diseases 1

Interventions

Radiotherapy 3Radiation 3palbociclib 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Doxorubicin 2zimberelimab 1talimogene laherparepvec 1sotigalimab 1ribociclib 1pazopanib 1eribulin 1enzalutamide 1durvalumab 1cemiplimab 1abemaciclib 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Nivolumab 1Midazolam 1Letrozole 1Ipilimumab 1Ifosfamide 1Fulvestrant 1Everolimus 1Disulfides 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Liposarcoma × abemaciclib × Clear all
NCT02846987 2025-06-05

Study of Abemaciclib in Dedifferentiated Liposarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
33 enrolled
Sarcoma

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡